What’s news around the hedge fund industry for Tuesday, July 31, 2012:

Around the web

Herbalife still haunted by ghost of David Einhorn. (Deal Journal)

Affiliated Managers Group ups BlueMountain stake. (WSJ.com)

Judge’s daughter, Martha Stewart’s friend don’t make the cut at Doug Whitman’s insider trading trial. (WSJ’s Law Blog)

Doug Whitman: Corporate crusader or inside trader? (WSJ’s Law Blog)

Tiger Management helps next generation funds. (DealBook)

Carrerist confusion on Wall Street. (New York Magazine)

ICE to overhaul trading in some energy contracts. (WSJ.com)

Dan Loeb: Biggest chapter yet for a poison pen. (WSJ.com)

Hedge funds stay defensive despite rally. (Financial Times)

Lazard shutters Korea fund as CICC closes Asia strategy. (Asian Investor)

Texas Permanent School Fund re-evaluates hedge fund portfolio. (HedgeFund.net)

Big Asian investors cut exposure to risky assets. (WSJ.com)

MGM film studio to buy out Carl Icahn. (Dow Jones Newswires, via WSJ.com)

Iran sentences four to death for bank fraud. (Reuters) Somewhere between this and “letting them off the hook completely” is a good regulatory regime.

One banking rule on liquidity that regulators are rounding on. (DealBook)

This entry was posted on Tuesday, July 31st, 2012 at 6:38 pm and is filed under News Roundup. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.